fep bcbs glp 1 coverage Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Tier exceptions no longer allowed

If patients develop constipation, then I usually treat with an osmotic laxative without lowering the dose

Until the FDA completes the next steps, patients and prescribers should treat the result as an important recommendationnot a completed policy change

the polyvalent linker comprises a 2-dithioalkyloxycarbonyl where the carbonyl forms a carbamate with the drug

Infusion of GLP-1 into healthy humans and diabetics by several groups established the role of GLP-1 as an incretin and a potential therapeutic for diabetes

researchers note it is more selective than older growth-hormone-releasing peptides (GHRPs) like GHRP-6 because it does not meaningfully raise cortisol or prolactin alongside GH